Diabetes type2 Clinical Trial
Official title:
Hyposalivation Response To Transcutaneous Electrical Nerve Stimulation In Diabetic Type 2 Patients
This study evaluates response of abnormal low salivary flow rate to transcutaneous electrical nerve stimulation (TENS) in diabetic type 2 patients. Response of saliva monitored for all participants receiving only one session of 5-minute extraoral TENS on bilateral parotid glands.
Diabetes mellitus is the most significant disorder associated with varied oral manifestation
ranging from xerostomia (subjective sensation od dry mouth) to serious bacterial and fungal
infections due to alterations in flow rate of saliva.
Systemic agents increase rate of stimulated salivary flow but often have unfavourable side
effects such as profuse sweating, rhinitis, dyspepsia.
Use of TENS in stimulation of saliva has been studied in the past which showed moderate
promising results. However, it never became a part of the mainstream therapy of
hyposalivation.
It has been postulated that transcutaneous electric nerve stimulation (TENS) could directly
stimulate the auriculotemporal nerve, which supplies the parotid gland, whereas it remains
unclear whether there is also an indirect action (via afferent pathways) onto the salivary
reflex arch.
Starting a prevention program as early as possible considering the most practical, cost
effective and efficient treatments with the best risk-benefit ratio will help to diminish dry
mouth symptoms and sequelae (intraoral and extraoral complications).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04164602 -
The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly
|
||
| Completed |
NCT05915338 -
Training on Using ıInsulin in Patients With Type 2 Diabetes
|
||
| Not yet recruiting |
NCT04998461 -
Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells
|
||
| Not yet recruiting |
NCT04880005 -
Digital Individualized and Collaborative Treatment of T2D in General Practice Based on Decision Aid
|
N/A | |
| Recruiting |
NCT05365529 -
Time-Restricted Eating for Type II Diabetes: TRE-T2D
|
N/A | |
| Recruiting |
NCT03958591 -
Effects of Short-term Intensive De-escalation Therapy on Long-term Regimen Simplification
|
Phase 4 | |
| Completed |
NCT05284071 -
Actiste® Diabetes Management as a Service (ADMS) Clinical Investigation
|
N/A | |
| Recruiting |
NCT05501093 -
Diabetes Reversal and the Subgingival Microbiota
|
||
| Active, not recruiting |
NCT05784220 -
The Canadian Diabetes Prevention Program
|
N/A | |
| Active, not recruiting |
NCT04286555 -
Dietary Approaches to Stop Hypertension for Diabetes
|
N/A | |
| Completed |
NCT05076656 -
Epigenetic and Microbiota Modifications
|
Early Phase 1 | |
| Completed |
NCT04423302 -
Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)
|
N/A | |
| Completed |
NCT05928637 -
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
|
Phase 1 | |
| Active, not recruiting |
NCT04660630 -
A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias
|
N/A | |
| Recruiting |
NCT04447859 -
16-week Flexible vs. 8-week Semaglutide Titration
|
Phase 3 | |
| Not yet recruiting |
NCT03968354 -
NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand (RANKL)
|
||
| Terminated |
NCT04819256 -
Primary Care Based Integrated Community Care Team Intervention
|
N/A | |
| Recruiting |
NCT05629221 -
Organisational Models Supported by Technology for the Management of Diabetic Disease and Its Complications in a Diabetic Clinic Setting. A Randomised Controlled Trial Targeting Type 2 Diabetes Individuals With Non-ideal Glycemic Values
|
N/A | |
| Completed |
NCT05260983 -
Acceptance and Commitment Therapy Principles for Diabetes Prevention
|
N/A |